Early Detection Research Network

Developed the first EDRN large, multi-center cross-sectional trial of biomarkers for the early detection of hepatocellular carcinoma (HCC)

Demonstrated that des-carboxyprothrombin (DCP) has a significant advantage over AFP for detecting HCC with viral etiology